A team of scientists from the University of Toronto has tested and found that the SARS-CoV-2 virus that causes COVID-19 can be stopped by the TrioMed Active mask. The outer surface of the mask deactivates 99% of viruses within a few minutes.

The Type IIR TrioMed Active Mask uses TrioMed technology and provides an extended level of active protection for healthcare professionals and the general public. Patented antimicrobial technology is at the heart of the company's entire line of medical products such as dressings, gloves, hats, gowns and other personal protective equipment sold worldwide.

A study published in the American Journal of Infection Control found that people touch their face an average of 23 times per hour. In addition, according to a study published in The Lancet Microbe, the coronavirus stays on the outer layer of masks is up to 7 days. These two scientific publications demonstrate a serious flaw in the level of protection of all mask wearers.

“The TrioMed Active Mask is the first and only respiratory protection that has been scientifically proven to deactivate the virus that causes COVID-19 and therefore significantly reduces the risk of infection for the user,” says Pierre Jean Messier, Founder and CEO of i3 Biomedical Inc. “Our company has spent years and millions of dollars developing this antimicrobial technology. The resulting products are used by the medical community around the world and have been tested by independent laboratories to kill numerous microbes such as MRSA, VRE, E-Coli, Staphylococcus Aureus, influenza virus and now SARS-CoV-2 … This third-party scientific testing confirms TrioMed's leadership position in medical antimicrobial technology available in the global fight against COVID-19.”

In this Article